DrugPatentWatch Database Preview
Patent: 10,150,800
Try a free trial
See Plans and Pricing
Summary for Patent: 10,150,800
| Title: | EGFR-binding modular recognition domains |
| Abstract: | EGFR-binding modular recognition domains (MRDs) and complexes containing such MRDs linked to antibodies are described. The use of such MRDs and complexes are also described. |
| Inventor(s): | Roschke; Viktor (Bethesda, MD), Lafleur; David (Washington, DC), Hilbert; David M. (Bethesda, MD), Kiener; Peter (Potomac, MD) |
| Assignee: | Zyngenia, Inc. (Washington, DC) |
| Application Number: | 14/776,816 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,150,800
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Imclone | ERBITUX | cetuximab | VIAL; INTRAVENOUS | 125084 | 001 | 2004-06-18 | ➤ Sign Up | Zyngenia, Inc. (Washington, DC) | 2038-12-14 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,150,800
| Country | Patent Number | Publication Date |
|---|---|---|
| Brazil | 112015023752 | Oct 24, 2017 |
| Canada | 2907181 | Sep 18, 2014 |
| China | 105451767 | Mar 30, 2016 |
| Eurasian Patent Organization | 201591546 | Jun 30, 2016 |
| Eurasian Patent Organization | 201890895 | Feb 28, 2019 |
| European Patent Office | 2968541 | Feb 08, 2017 |
| >Country | >Patent Number | >Publication Date |
